Stay updated with the latest glimepiride news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on glimepiride topics.
Bengaluru : Emcure Pharmaceuticals Ltd. ("Emcure") and Sanofi India Limited ("SIL") today entered into an exclusive distribution and promotion agreement for SIL's oral anti-diabetic (OAD) products in India, effective immediately. Emcure will exclusively distribute and promote the Company's OAD range of products that include well-established brands like Amaryl® and Cetapin®. While SIL will continue to own and manufacture these brands across Sanofi's plants in India and internationally, Emcure w ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.